TREVICTA

This brand name is authorized in Nigeria. It is also authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug TREVICTA contains one active pharmaceutical ingredient (API):

1	Paliperidone UNII R8P8USM8FR - PALIPERIDONE PALMITATE
	Paliperidone is a selective blocking agent of monoamine effects, whose pharmacological properties are different from that of traditional neuroleptics. Even though paliperidone is a strong D2-antagonist, which is believed to relieve the positive symptoms of schizophrenia, it causes less catalepsy and decreases motor functions to a lesser extent than traditional neuroleptics.
	Read more about Paliperidone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100553	Suspension for injection	TREVICTA 263 mg prolonged release suspension for injection INJ_SUSP 263mg 1 X 1	48 NF-PP-268959 TREVICTA 263 mg prolonged release suspension for injection Paliperidone palmitate Each TREVICTA 263 mg pre filled syringe contains 410 mg paliperidone palmitate The other ingredients are: Polysorbate 20 Polyethylene glycol 4000 Citric acid monohydrate Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injections A4-100553 Drugs Imported Products 11 Prescription Only Medicine (POM) 7/17/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 uugwulek@its.jnj.com JANSSEN PHARMACEUTICA N.V, TURNHOUTSEWEG 30, B-2340 BEERSE, BELGIUM, Belgium	31/10/2023
A4-100554	Suspension for injection	TREVICTA 175mg prolonged release suspension for injection INJ_SUSP 175mg 1 X 1	49 NF-PP-268978 TREVICTA 175mg prolonged release suspension for injection Paliperidone palmitate Each prefilled syringe contains 273 mg paliperidone palmitate equivalent to 175 mg paliperidone. Excipients include Polysorbate 20 Polyethylene glycol 4000 Citric acid monohydrate Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injections A4-100554 Drugs Imported Products 11 Prescription Only Medicine (POM) 7/17/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 uugwulek@its.jnj.com JANSSEN PHARMACEUTICA N.V, TURNHOUTSEWEG 30, B-2340 BEERSE, BELGIUM, Belgium	31/10/2023
A4-100578	Suspension for injection	TREVICTA 525 MG PROLONGED RELEASE SUSPENSION FOR INJECTION INJ_SUSP 525mg 1 X 1	72 NF-PP-341933 TREVICTA 525 MG PROLONGED RELEASE SUSPENSION FOR INJECTION Paliperidone Palmitate Each pre filled syringe contains 819 mg paliperidone palmitate equivalent to 525 mg paliperidone. Excipients include: Polysorbate 20 Polyethylene glycol 4000 Citric acid monohydrate Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injections A4-100578 Drugs Imported Products 11 Prescription Only Medicine (POM) 7/17/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 uugwulek@its.jnj.com JANSSEN PHARMACEUTICA N.V, TURNHOUTSEWEG 30, B-2340 BEERSE, BELGIUM, Belgium	31/10/2023
A4-100677	Injection	TREVICTA 350 MG PROLONGED RELEASE SUSPENSION FOR INJECTION INJ 350mg 1 X 1	27 NF-PP-341930 TREVICTA 350 MG PROLONGED RELEASE SUSPENSION FOR INJECTION Paliperidone Palmitate Each prefilled syringe contains 546 mg paliperidone palmitate equivalent to 350 mg paliperidone. Excipients include Polysorbate 20 Polyethylene glycol 4000 Citric acid monohydrate Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injections A4-100677 Drugs Imported Products 11 Prescription Only Medicine (POM) 7/17/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 uugwulek@its.jnj.com JANSSEN PHARMACEUTICA N.V, TURNHOUTSEWEG 30, B-2340 BEERSE, BELGIUM, Belgium	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AX13	Paliperidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1721360, 1721371, 1721382, 1721393
ES	Centro de información online de medicamentos de la AEMPS	114971007, 114971008, 114971009, 114971010
FI	Lääkealan turvallisuus- ja kehittämiskeskus	415635, 440410, 493496, 527714
FR	Base de données publique des médicaments	60249796, 61444322, 68924929, 69642982
GB	Medicines & Healthcare Products Regulatory Agency	328670, 328679, 328682, 328685
IE	Health Products Regulatory Authority	34240, 34241, 34242, 34243, 62898
IL	מִשְׂרַד הַבְּרִיאוּת	7921, 7922, 7923, 7924
IT	Agenzia del Farmaco	043799079, 043799081, 043799093, 043799105
LT	Valstybinė vaistų kontrolės tarnyba	1080478, 1080479, 1080480, 1080481
NG	Registered Drug Product Database	A4-100553, A4-100554, A4-100578, A4-100677
NL	Z-Index G-Standaard, PRK	132535, 132551, 132578, 136204
PL	Rejestru Produktów Leczniczych	100372448, 100372454, 100372460, 100372477
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62903001, W62904001, W62905001, W62906001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699593950087, 8699593950094, 8699593950100, 8699593950117